Provided in the present invention is an (R) albuterol pharmaceutically acceptable salt or pharmaceutical formulation thereof and the application thereof in the preparation of drugs for the treatment of diseases such as skin ulcers lesions purulence or delayed healing caused by trauma pressure sores tumours diabetes or coinfection. The pharmaceutical formulation contains the levalbuterol pharmaceutically acceptable salt or the levalbuterol pharmaceutically acceptable salt and hormones antibiotics or anti inflammatory drugs.